Antitumor peptides from marine organisms

Marine Drugs

Volumn 9, Issue 10, 2011, Pages 1840-1859

  Zheng, Lan Hong ^a   Wang, Yue Jun ^a   Sheng, Jun ^a   Wang, Fang ^a   Zheng, Yuan ^a   Lin, Xiu Kun ^b,c   Sun, Mi ^a  

^a YELLOW SEA FISHERIES RESEARCH INSTITUTE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Antitumor; Marine organisms; Peptides

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLODEPSIPEPTIDE; CYCLOXAZOLINE; DEHYDRODIDEMNIN B; DIAZONAMIDE A; DIDEMNIN B; DNA; DOLASTATIN 10; GUANOSINE TRIPHOSPHATASE; HEMIASTERLIN; HEXAPEPTIDE; JASPAMIDE; LIPOPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYCOCYANIN; PROTEIN BAX; PROTEIN BCL 2; SANSALVAMIDE A; SCLERITODERMIN A; SOMOCYSTINAMIDE A; STRESS ACTIVATED PROTEIN KINASE; TRIPEPTIDE DERIVATIVE; TUBULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRENAMIDE A; VIRENAMIDE B; VIRENAMIDE C; VITILEVUAMIDE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CELL CYCLE ARREST; DRUG CYTOTOXICITY; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; LYNGBYA MAJUSCULA; MARINE SPECIES; MICROTUBULE; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; SPONGE (PORIFERA);

EID: 80054931115     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9101840     Document Type: Review

References (131)

1. de Vries, D.J.; Beart, P.M. Fishing for drugs from the sea: Status and strategies. Trends Pharmacol. Sci. 1995, 16, 275-279.
2. Reed, J.C. Mechanisms of apoptosis. Am. J. Pathol. 2000, 157, 1415-1430.
3. Danial, N.N.; Korsmeyer, S.J. Cell death: Critical control points. Cell 2004, 116, 205-219. (Pubitemid 38167313)
4. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267, 1456-1462.
5. Rowinsky, E.K. Targeted induction of apoptosis in cancer management: The emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J. Clin. Oncol. 2005, 23, 9394-9407.
6. Call, J.A.; Eckhardt, S.G.; Camidge, D.R. Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol. 2008, 9, 1002-1011.
7. Iannolo, G.; Conticello, C.; Memeo, L.; de Maria, R. Apoptosis in normal and cancer stem cells. Crit. Rev. Oncol. Hematol. 2008, 66, 42-51.
8. Burz, C.; Berindan-Neagoe, I.; Balacescu, O.; Irimie, A. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol. 2009, 48, 811-821.
9. Fulda, S.; Pervaiz, S. Apoptosis signaling in cancer stem cells. Int. J. Biochem. Cell Biol. 2009, 42, 31-38.
10. Ghobrial, I.M.; Witzig, T.E.; Adjei, A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005, 55, 178-194. (Pubitemid 40826487)
11. Eberle, J.; Fecker, L.F.; Forschner, T.; Ulrich, C.; Rowert-Huber, J.; Stockfleth, E. Apoptosis pathways as promising targets for skin cancer therapy. Br. J. Dermatol. 2007, 156S, 18-24. (Pubitemid 46632507)
12. Ziegler, D.S.; Kung, A.L. Therapeutic targeting of apoptosis pathways in cancer. Curr. Opin. Oncol. 2008, 20, 97-103. (Pubitemid 350190988)
13. Cheng, L.; Wang, X.; Zhang, J.; Zhang, S.B.; Zheng, S.Q.; Zheng, J. Targeting apoptosis signaling pathways in cancer therapy. Zhonghua Bing Li Xue Za Zhi 2009, 38, 639-642.
14. Lin, X.; Liu, M.; Hu, C.; Liao, D.J. Targeting cellular proapoptotic molecules for developing anticancer agents from marine sources. Curr. Drug Targets 2010, 11, 708-715.
15. von Schwarzenberg, K.; Vollmar, A.M. Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy. Cancer Lett. 2010, doi:10.1016/j.canlet.2010.07.004.
16. Abe, K.; Kurakin, A.; Mohseni-Maybodi, M.; Kay, B.; Khosravi-Far, R. The complexity of TNF-related apoptosis-inducing ligand. Ann. N. Y. Acad. Sci. 2000, 926, 52-63. (Pubitemid 32050142)
17. Ozoren, N.; El-Deiry, W.S. Cell surface Death Receptor signaling in normal and cancer cells. Semin. Cancer Biol. 2003, 13, 135-147. (Pubitemid 36321814)
18. Peter, M.E.; Krammer, P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003, 10, 26-35. (Pubitemid 36511830)
19. Thorburn, A. Death receptor-induced cell killing. Cell Signal 2004, 16, 139-144. (Pubitemid 37431163)
20. Kroemer, G. Mitochondrial control of apoptosis: An introduction. Biochem. Biophys. Res. Commun. 2003, 304, 433-435. (Pubitemid 36511397)
21. Gupta, S.; Kass, G.E.; Szegezdi, E.; Joseph, B. The mitochondrial death pathway: A promising therapeutic target in diseases. J. Cell. Mol. Med. 2009, 13, 1004-1033.
22. Yip, K.W.; Reed, J.C. Bcl-2 family proteins and cancer. Oncogene 2008, 27, 6398-6406.
23. Okun, I.; Balakin, K.V.; Tkachenko, S.E.; Ivachtchenko, A.V. Caspase activity modulators as anticancer agents. Anticancer Agents Med. Chem. 2008, 8, 322-341. (Pubitemid 351761437)
24. Ghavami, S.; Hashemi, M.; Ande, S.R.; Yeganeh, B.; Xiao, W.; Eshraghi, M.; Bus, C.J.; Kadkhoda, K.; Wiechec, E.; Halayko, A.J.; Los, M. Apoptosis and cancer: Mutations within caspase genes. J. Med. Genet. 2009, 46, 497-510.
25. Park, H.J.; Kim, B.C.; Kim, S.J.; Choi, K.S. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Hepatology 2002, 35, 1360-1371. (Pubitemid 34966890)
26. Kang, M.H.; Reynolds, C.P. Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 2009, 15, 1126-1132.
27. Wong, W.W.; Puthalakath, H. Bcl-2 family proteins: The sentinels of the mitochondrial apoptosis pathway. IUBMB Life 2008, 60, 390-397.
28. Braekman, J.C.; Daloze, D.; Moussiaux, B.; Riccio, R. Jaspamide from the marine sponge Jaspis johnstoni. J. Nat. Prod. 1987, 50, 994-995.
29. Odaka, C.; Sanders, M.L.; Crews, P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin. Diagn. Lab. Immunol. 2000, 7, 947-952. (Pubitemid 32244495)
30. Cioca, D.P.; Kitano, K. Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells. Cell. Mol. Life Sci. 2002, 59, 1377-1387.
31. Nogle, L.M.; Gerwick, W.H. Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage. Org. Lett. 2002, 4, 1095-1098.
32. Wrasidlo, W.; Mielgo, A.; Torres, V.A.; Barbero, S.; Stoletov, K.; Suyama, T.L.; Klemke, R.L.; Gerwick, W.H.; Carson, D.A.; Stupack, D.G. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl. Acad. Sci. USA 2008, 105, 2313-2318. (Pubitemid 351520510)
33. Schirmer, T.; Huber, R.; Schneider, M.; Bode, W.; Miller, M.; Hackert, M.L. Crystal structure analysis and refinement at 2.5 Å of hexameric C-phycocyanin from the cyanobacterium Agmenellum quadruplicatum: The molecular model and its implications for light-harvesting. J. Mol. Biol. 1986, 188, 651-676.
34. Li, B.; Gao, M.H.; Zhang, X.C.; Chu, X.M. Molecular immune mechanism of C-phycocyanin from Spirulina platensis induces apoptosis in HeLa cells in vitro. Biotechnol. Appl. Biochem. 2006, 43, 155-164.
35. Dhanasekaran, D.N.; Reddy, E.P. JNK signaling in apoptosis. Oncogene 2008, 27, 6245-6251.
36. Wagner, E.F.; Nebreda, A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 2009, 9, 537-549.
37. Depenbrock, H.; Peter, R.; Faircloth, G.T.; Manzanares, I.; Jimeno, J.; Hanauske, A.R. In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells. Br. J. Cancer 1998, 78, 739-744. (Pubitemid 28418305)
38. Urdiales, J.L.; Morata, P.; de Castro, I.N.; Sánchez- Jiménez, F. Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett. 1996, 102, 31-37.
39. Garcia-Fernandez, L.F.; Losada, A.; Alcaide, V.; Alvarez, A.M.; Cuadrado, A.; Gonzalez, L.; Nakayama, K.; Nakayama, K.I.; Fernandez-Sousa, J.M.; Munoz, A.; et al. Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene 2002, 21, 7533-7544.
40. Rinehart, K.L. Antitumor compounds from tunicates. Med. Res. Rev. 2000, 20, 1-27. (Pubitemid 30027559)
41. Faivre, S.; Chieze, S.; Delbaldo, C.; Ady-Vago, N.; Guzman, C.; Lopez-Lazaro, L.; Lozahic, S.; Jimeno, J.; Pico, F.; Armand, J.P.; et al. Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies. J. Clin. Oncol. 2005, 23, 7871-7880.
42. Maroun, J.A.; Belanger, K.; Seymour, L.; Matthews, S.; Roach, J.; Dionne, J.; Soulieres, D.; Stewart, D.; Goel, R.; Charpentier, D.; et al. Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115. Ann. Oncol. 2006, 17, 1371-1378.
43. Nalda-Molina, R.; Valenzuela, B.; Ramon-Lopez, A.; Miguel-Lillo, B.; Soto-Matos, A.; Perez-Ruixo, J.J. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects. Cancer Chemother. Pharmacol. 2009, 64, 97-108.
44. Rinehart, K.L.; Gloer, J.B.; Cook, J.C.; Mizsak, S.A.; Scahill, T.A. Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate. J. Am. Chem. Soc. 1981, 103, 1857-1859.
45. Rinehart, K., Jr.; Gloer, J.; Hughes, R., Jr.; Renis, H.; McGovren, J.; Swynenberg, E.; Stringfellow, D.; Kuentzel, S.; Li, L. Didemnins: Antiviral and antitumor depsipeptides from a caribbean tunicate. Science 1981, 212, 933-935.
46. Schmitz, F.; Bowden, B.; Toth, S. Antitumor and cytotoxic compounds from marine organisms. Mar. Biotechnol. 1993, 1, 197-308.
47. Blunden, G. Biologically active compounds from marine organisms. Phytother. Res. 2001, 15, 89-94.
48. Grubb, D.R.; Wolvetang, E.J.; Lawen, A. Didemnin B induces cell death by apoptosis: The fastest induction of apoptosis ever described. Biochem. Biophys. Res. Commun. 1995, 215, 1130-1136.
49. Johnson, K.L.; Lawen, A. Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: Evidence for the possible involvement of FK506-binding protein 25. Immunol. Cell Biol. 1999, 77, 242-248. (Pubitemid 29251577)
50. Vervoort, H.; Fenical, W.; Epifanio, R.A. Tamandarins A and B: New cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae. J. Org. Chem. 2000, 65, 782-792.
51. Chun, H.; Davies, B.; Hoth, D.; Suffness, M.; Plowman, J.; Flora, K.; Grieshaber, C.; Leyland-Jones, B. Didemnin B. Investig. New Drugs 1986, 4, 279-284.
52. Rinehart, K.L.; Holt, T.G.; Fregeau, N.L.; Keifer, P.A.; Wilson, G.R.; Perun, T.J.; Sakai, R.; Thompson, A.G.; Stroh, J.G.; Shield, L.S.; Seigler, D.S.; Li, L.H.; Martin, D.G.; Grimmelikhuijzen, C.J.P.; Gäde, G. Bioactive Compounds from Aquatic and Terrestrial Sources. J. Nat. Prod. 1990, 53, 771-792. (Pubitemid 20334534)
53. Hwang, Y.; Rowley, D.; Rhodes, D.; Gertsch, J.; Fenical, W.; Bushman, F. Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A. Mol. Pharmacol. 1999, 55, 1049-1053. (Pubitemid 29252371)
54. Pan, P.S.; Vasko, R.C.; Lapera, S.A.; Johnson, V.A.; Sellers, R.P.; Lin, C.C.; Pan, C.M.; Davis, M.R.; Ardi, V.C.; McAlpine, S.R. A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines. Bioorg. Med. Chem. 2009, 17, 5806-5825.
55. Hambley, T.W.; Hawkins, C.J.; Lavin, M.F.; van den Brenk, A.; Watters, D.J. Cycloxazoline: A cytotoxic cyclic hexapeptide from the ascidian lissoclinum bistratum. Tetrahedron 1992, 48, 341-348.
56. Watters, D.J.; Beamish, H.J.; Marshall, K.A.; Gardiner, R.A.; Seymour, G.J.; Lavin, M.F. Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline. Cancer Chemother. Pharmacol. 1994, 33, 399-409. (Pubitemid 24057692)
57. Carroll, A.R.; Feng, Y.; Bowden, B.F.; Coll, J.C. Studies of Australian Ascidians. 5. Virenamides A-C, New Cytotoxic Linear Peptides from the Colonial Didemnid Ascidian Diplosoma virens. J. Org. Chem. 1996, 61, 4059-4061. (Pubitemid 26201408)
58. Hadfield, J.A.; Ducki, S.; Hirst, N.; McGown, A.T. Tubulin and microtubules as targets for anticancer drugs. Prog. Cell Cycle Res. 2003, 5, 309-325.
59. Islam, M.N.; Iskander, M.N. Microtubulin binding sites as target for developing anticancer agents. Mini Rev. Med. Chem. 2004, 4, 1077-1104. (Pubitemid 39545451)
60. Pettit, G.R.; Kamano, Y.; Fujii, Y.; Herald, C.L.; Inoue, M.; Brown, P.; Gust, D.; Kitahara, K.; Schmidt, J.M.; Doubek, D.L.; Michel, C. Marine animal biosynthetic constituents for cancer chemotherapy. J. Nat. Prod. 1981, 44, 482-485.
61. Luesch, H.; Moore, R.E.; Paul, V.J.; Mooberry, S.L.; Corbett, T.H. Isolation of Dolastatin 10 from the Marine Cyanobacterium Symploca Species VP642 and Total Stereochemistry and Biological Evaluation of Its Analogue Symplostatin 1. J. Nat. Prod. 2001, 64, 907-910. (Pubitemid 32729902)
62. Bai, R.; Pettit, G.R.; Hamel, E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the Vinca alkaloid binding domain. Biochem. Pharmacol. 1990, 39, 1941-1949. (Pubitemid 20187330)
63. Bai, R.L.; Pettit, G.R.; Hamel, E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and Vinca alkaloid sites. J. Biol. Chem. 1990, 265, 17141-17149. (Pubitemid 20334257)
64. Edler, M.C.; Fernandez, A.M.; Lassota, P.; Ireland, C.M.; Barrows, L.R. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the Vinca alkaloids, and dolastatin 10. Biochem. Pharmacol. 2002, 63, 707-715. (Pubitemid 34457702)
65. Cruz-Monserrate, Z.; Vervoort, H.C.; Bai, R.; Newman, D.J.; Howell, S.B.; Los, G.; Mullaney, J.T.; Williams, M.D.; Pettit, G.R.; Fenical, W.; Hamel, E. Diazonamide A and a synthetic structural analog: Disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin. Mol. Pharmacol. 2003, 63, 1273-1280. (Pubitemid 36627221)
66. Lachia, M.; Moody, C.J. The synthetic challenge of diazonamide A, a macrocyclic indole bis-oxazole marine natural product. Nat. Prod. Rep. 2008, 25, 227-253. (Pubitemid 351490292)
67. Schmidt, E.W.; Raventos-Suarez, C.; Bifano, M.; Menendez, A.T.; Fairchild, C.R.; Faulkner, D.J. Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum. J. Nat. Prod. 2004, 67, 475-478. (Pubitemid 38405721)
68. Liu, S.; Cui, Y.M.; Nan, F.J. Total synthesis of the originally proposed and revised structures of scleritodermin A. Org. Lett. 2008, 10, 3765-3768.
69. Anderson, H.J.; Coleman, J.E.; Andersen, R.J.; Roberge, M. Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemother. Pharmacol. 1997, 39, 223-226. (Pubitemid 26414259)
70. Gamble, W.R.; Durso, N.A.; Fuller, R.W.; Westergaard, C.K.; Johnson, T.R.; Sackett, D.L.; Hamel, E.; Cardellina Ii, J.H.; Boyd, M.R. Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges. Bioorg. Med. Chem. 1999, 7, 1611-1165.
71. Loganzo, F.; Discafani, C.M.; Annable, T.; Beyer, C.; Musto, S.; Hari, M.; Tan, X.; Hardy, C.; Hernandez, R.; Baxter, M.; et al. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Res. 2003, 63, 1838-1845.
72. Yamashita, A.; Norton, E.B.; Kaplan, J.A.; Niu, C.; Loganzo, F.; Hernandez, R.; Beyer, C.F.; Annable, T.; Musto, S.; Discafani, C.; et al. Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: Modification of the A segment. Bioorg. Med. Chem. Lett. 2004, 14, 5317-5322.
73. Simmons, T.L.; Nogle, L.M.; Media, J.; Valeriote, F.A.; Mooberry, S.L.; Gerwick, W.H. Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. J. Nat. Prod. 2009, 72, 1011-1016.
74. Chevallier, C.; Richardson, A.D.; Edler, M.C.; Hamel, E.; Harper, M.K.; Ireland, C.M. A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge Cymbastela sp. Org. Lett. 2003, 5, 3737-3739. (Pubitemid 37289568)
75. Ning, X.; Zhao, J.; Zhang, Y.; Cao, S.; Liu, M.; Ling, P.; Lin, X. A novel anti-tumor protein extracted from Meretrix meretrix Linnaeus induces cell death by increasing cell permeability and inhibiting tubulin polymerization. Int. J. Oncol. 2009, 35, 805-812.
76. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 1992, 3, 65-71.
77. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1, 27-31.
78. Bouck, N.; Stellmach, V.; Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 1996, 69, 135-174. (Pubitemid 26274885)
79. Folkman, J. Angiogenesis and angiogenesis inhibition: An overview. EXS 1997, 79, 1-8.
80. Ferrara, N. VEGF: An update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 2000, 11, 617-624.
81. Ferrara, N.; Gerber, H.P.; LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 2003, 9, 669-676. (Pubitemid 36749215)
82. Nakamura, S.; Chikaraishi, Y.; Tsuruma, K.; Shimazawa, M.; Hara, H. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. Exp. Eye Res. 2009, 90, 137-145.
83. Ushio-Fukai, M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc. Res. 2006, 71, 226-235.
84. Chiavarina, B.; Whitaker-Menezes, D.; Migneco, G.; Martinez-Outschoorn, U.E.; Pavlides, S.; Howell, A.; Tanowitz, H.B.; Casimiro, M.C.; Wang, C.; Pestell, R.G.; et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010, 9, 3534-3551.
85. Fukushima, K.; Murata, M.; Hachisuga, M.; Tsukimori, K.; Seki, H.; Takeda, S.; Asanoma, K.; Wake, N. Hypoxia inducible factor 1 alpha regulates matrigel-induced endovascular differentiation under normoxia in a human extravillous trophoblast cell line. Placenta 2008, 29, 324-331.
86. Lee, A.; Langer, R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983, 221, 1185-1187. (Pubitemid 13001233)
87. Dupont, E.; Brazeau, P.; Juneau, C. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression: Process of making thereof. U.S. Patents 5,985,839, 16 November 1999.
88. Lee, S.Y.; Chung, S.M. Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression. Vasc. Pharmacol. 2007, 47, 313-318.
89. Zheng, L.; Ling, P.; Wang, Z.; Niu, R.; Hu, C.; Zhang, T.; Lin, X. A novel polypeptide from shark cartilage with potent anti-angiogenic activity. Cancer Biol. Ther. 2007, 6, 775-780. (Pubitemid 47328361)
90. Morgan, J.B.; Mahdi, F.; Liu, Y.; Coothankandaswamy, V.; Jekabsons, M.B.; Johnson, T.A.; Sashidhara, K.V.; Crews, P.; Nagle, D.G.; Zhou, Y.D. The marine sponge metabolite mycothiazole: A novel prototype mitochondrial complex I inhibitor. Bioorg. Med. Chem. 2010, 18, 5988-5994.
91. McDonald, L.A.; Ireland, C.M. Patellamide E: A new cyclic peptide from the ascidian Lissoclinum patella. J. Nat. Prod. 1992, 55, 376-379.
92. Rashid, M.A.; Gustafson, K.R.; Cardellina, J.H., II; Boyd, M.R. Patellamide F, A new cytotoxic cyclic peptide from the colonial ascidian Lissoclinum patella. J. Nat. Prod. 1995, 58, 594-597.
93. Fu, X.; Do, T.; Schmitz, F.J.; Andrusevich, V.; Engel, M.H. New cyclic peptides from the ascidian Lissoclinum patella. J. Nat. Prod. 1998, 61, 1547-1551. (Pubitemid 29024437)
94. Fu, X.; Su, J.; Zeng, L. Prepatellamide A, a new cyclic peptide from the ascidian Lissoclinum patella. Sci. China Ser. B Chem. 2000, 43, 643-648.
95. Taylor, S.W.; Craig, A.G.; Fischer, W.H.; Park, M.; Lehrer, R.I. Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. J. Biol. Chem. 2000, 275, 38417-38426. (Pubitemid 32009166)
96. Swersey, J.C.; Ireland, C.M.; Cornell, L.M.; Peterson, R.W. Eusynstyelamide, a highly modified dimer peptide from the ascidian Eusynstyela misakiensis. J. Nat. Prod. 1994, 57, 842-845.
97. McDonald, L.A.; Christopher Swersey, J.; Ireland, C.M.; Carroll, A.R.; Coll, J.C.; Bowden, B.F.; Fairchild, C.R.; Cornell, L. Botryllamides A-D, new brominated tyrosine derivatives from styelid ascidians of the genus Botryllus. Tetrahedron 1995, 51, 5237-5244.
98. Degnan, B.M.; Hawkins, C.J.; Lavin, M.F.; McCaffrey, E.J.; Parry, D.L.; van den Brenk, A.L.; Watters, D.J. New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella. J. Med. Chem. 1989, 32, 1349-1354. (Pubitemid 19149993)
99. Hawkins, C.J.; Lavin, M.F.; Marshall, K.A.; van den Brenk, A.L.; Watters, D.J. Structure-activity relationships of the lissoclinamides: Cytotoxic cyclic peptides from the ascidian Lissoclinum patella. J. Med. Chem. 1990, 33, 1634-1638. (Pubitemid 20180621)
100. Donia, M.S.; Wang, B.; Dunbar, D.C.; Desai, P.V.; Patny, A.; Avery, M.; Hamann, M.T. Mollamides B and C, Cyclic hexapeptides from the indonesian tunicate Didemnum molle. J. Nat. Prod. 2008, 71, 941-945. (Pubitemid 352008885)
101. Carroll, A.R.; Bowden, B.F.; Coll, J.C.; Hockless, D.C.R.; Skelton, B.W.; White, A.H. Studies of Australian Ascidians. IV. Mollamide, a Cytotoxic Cyclic Heptapeptide from the Compound Ascidian Diplosoma virens. Aust. J. Chem. 1994, 47, 61-69.
102. Sonnenschein, R.N.; Farias, J.J.; Tenney, K.; Mooberry, S.L.; Lobkovsky, E.; Clardy, J.; Crews, P. A further study of the cytotoxic constituents of a milnamide-producing sponge. Org. Lett. 2004, 6, 779-782. (Pubitemid 38387974)
103. Coleman, J.E.; van Soest, R.; Andersen, R.J. New geodiamolides from the sponge Cymbastela sp. collected in Papua New Guinea. J. Nat. Prod. 1999, 62, 1137-1141. (Pubitemid 29418340)
104. Fusetani, N.; Sugawara, T.; Matsunaga, S.; Hirota, H. Orbiculamide A: A novel cytotoxic cyclic peptide from a marine sponge Theonella sp. J. Am. Chem. Soc. 1991, 113, 7811-7812.
105. Araki, T.; Matsunaga, S.; Nakao, Y.; Furihata, K.; West, L.; Faulkner, D.J.; Fusetani, N. Koshikamide B, a cytotoxic peptide lactone from a marine sponge Theonella sp. J. Org. Chem. 2008, 73, 7889-7894.
106. Pettit, G.R.; Cichacz, Z.; Barkoczy, J.; Dorsaz, A.C.; Herald, D.L.; Williams, M.D.; Doubek, D.L.; Schmidt, J.M.; Tackett, L.P.; Brune, D.C.; et al. Isolation and structure of the marine sponge cell growth inhibitory cyclic peptide phakellistatin 1. J. Nat. Prod. 1993, 56, 260-267.
107. Pettit, G.R.; Tan, R.; Ichihara, Y.; Williams, M.D.; Doubek, D.L.; Tackett, L.P.; Schmidt, J.M.; Cerny, R.L.; Boyd, M.R.; Hooper, J.N. Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp. J. Nat. Prod. 1995, 58, 961-965.
108. Pettit, G.R.; Tan, R. Antineoplastic agents 390. Isolation and structure of phakellistatin 12 from a Chuuk archipelago marine sponge. Bioorg. Med. Chem. Lett. 2003, 13, 685-688. (Pubitemid 36298468)
109. Pettit, G.R.; Tan, R. Isolation and structure of phakellistatin 14 from the Western Pacific marine sponge Phakellia sp. J. Nat. Prod. 2005, 68, 60-63. (Pubitemid 40175930)
110. Davis, R.A.; Mangalindan, G.C.; Bojo, Z.P.; Antemano, R.R.; Rodriguez, N.O.; Concepcion, G.P.; Samson, S.C.; de Guzman, D.; Cruz, L.J.; Tasdemir, D.; Harper, M.K.; Feng, X.; Carter, G.T.; Ireland, C.M. Microcionamides A and B, Bioactive Peptides from the Philippine Sponge Clathria (Thalysias) abietina. J. Org. Chem. 2004, 69, 4170-4176. (Pubitemid 38736481)
111. Li, H.; Matsunaga, S.; Fusetani, N. Halicylindramides D and E, antifungal peptides from the marine sponge Halichondria cylindrata. J. Nat. Prod. 1996, 59, 163-166. (Pubitemid 27079837)
112. Rashid, M.A.; Gustafson, K.R.; Boswell, J.L.; Boyd, M.R. Haligramides A and B, two new cytotoxic hexapeptides from the marine sponge Haliclona nigra. J. Nat. Prod. 2000, 63, 956-959. (Pubitemid 30624480)
113. Bai, R.; Durso, N.A.; Sackett, D.L.; Hamel, E. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: Comparison with dolastatin 10 and cryptophycin 1. Biochemistry 1999, 38, 14302-14310.
114. Crews, P.; Farias, J.J.; Emrich, R.; Keifer, P.A. Milnamide A, an unusual cytotoxic tripeptide from the marine sponge Auletta cf. constricta. J. Org. Chem. 1994, 59, 2932-2934. (Pubitemid 24216863)
115. Laird, D.W.; LaBarbera, D.V.; Feng, X.; Bugni, T.S.; Harper, M.K.; Ireland, C.M. Halogenated cyclic peptides isolated from the sponge Corticium sp. J. Nat. Prod. 2007, 70, 741-746. (Pubitemid 46953592)
116. Ratnayake, A.S.; Bugni, T.S.; Feng, X.; Harper, M.K.; Skalicky, J.J.; Mohammed, K.A.; Andjelic, C.D.; Barrows, L.R.; Ireland, C.M. Theopapuamide, a cyclic depsipeptide from a Papua New Guinea lithistid sponge Theonella swinhoei. J. Nat. Prod. 2006, 69, 1582-1586. (Pubitemid 46031809)
117. Bishara, A.; Rudi, A.; Aknin, M.; Neumann, D.; Ben-Califa, N.; Kashman, Y. Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis sp. Org. Lett. 2008, 10, 4307-4309.
118. Fusetani, N.; Warabi, K.; Nogata, Y.; Nakao, Y.; Matsunaga, S.; van Soest, R.R.M. Koshikamide A1, a new cytotoxic linear peptide isolated from a marine sponge, Theonella sp. Tetrahedron Lett. 1999, 40, 4687-4690.
119. Araki, T.; Matsunaga, S.; Fusetani, N. Koshikamide A2, a cytotoxic linear undecapeptide isolated from a marine sponge of Theonella sp. Biosci. Biotechnol. Biochem. 2005, 69, 1318-1322. (Pubitemid 41185215)
120. Boot, C.M.; Tenney, K.; Valeriote, F.A.; Crews, P. Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium sp. J. Nat. Prod. 2006, 69, 83-92. (Pubitemid 43241760)
121. Wesson, K.J.; Hamann, M.T. Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii. J. Nat. Prod. 1996, 59, 629-631. (Pubitemid 26239379)
122. Kimura, J.; Takada, Y.; Inayoshi, T.; Nakao, Y.; Goetz, G.; Yoshida, W.Y.; Scheuer, P.J. Kulokekahilide-1, a cytotoxic depsipeptide from the cephalaspidean mollusk Philinopsis speciosa. J. Org. Chem. 2002, 67, 1760-1767. (Pubitemid 34246566)
123. Nakao, Y.; Yoshida, W.Y.; Takada, Y.; Kimura, J.; Yang, L.; Mooberry, S.L.; Scheuer, P.J. Kulokekahilide-2, a cytotoxic depsipeptide from a cephalaspidean mollusk Philinopsis speciosa. J. Nat. Prod. 2004, 67, 1332-1340. (Pubitemid 39145639)
124. Yu, Z.; Lang, G.; Kajahn, I.; Schmaljohann, R.; Imhoff, J.F. Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis. J. Nat. Prod. 2008, 71, 1052-1054. (Pubitemid 352008904)
125. Linington, R.G.; Edwards, D.J.; Shuman, C.F.; McPhail, K.L.; Matainaho, T.; Gerwick, W.H. Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp. J. Nat. Prod. 2008, 71, 22-27. (Pubitemid 351236389)
126. Stolze, S.C.; Meltzer, M.; Ehrmann, M.; Kaiser, M. Solid phase total synthesis of the 3-amino-6-hydroxy-2-piperidone (Ahp) cyclodepsipeptide and protease inhibitor Symplocamide A. Chem. Commun. 2010, 46, 8857-8859.
127. Gutierrez, M.; Suyama, T.L.; Engene, N.; Wingerd, J.S.; Matainaho, T.; Gerwick, W.H. Apratoxin D, a potent cytotoxic cyclodepsipeptide from papua new guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J. Nat. Prod. 2008, 71, 1099-1103. (Pubitemid 352008918)
128. Liu, L.; Rein, K.S. New peptides isolated from Lyngbya species: A review. Mar. Drugs 2010, 8, 1817-1837.
129. Andrianasolo, E.H.; Goeger, D.; Gerwick, W.H. Mitsoamide: A cytotoxic linear lipopeptide from the Madagascar marine cyanobacterium Geitlerinema sp. Pure Appl. Chem. 2007, 79, 593-602.
130. Maki, A.; Diwakaran, H.; Redman, B.; al-Asfar, S.; Pettit, G.R.; Mohammad, R.M.; al-Katib, A. The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma. Anticancer Drugs 1995, 6, 392-397.
131. Taraboletti, G.; Poli, M.; Dossi, R.; Manenti, L.; Borsotti, P.; Faircloth, G.T.; Broggini, M.; D'Incalci, M.; Ribatti, D.; Giavazzi, R. Antiangiogenic activity of aplidine, a new agent of marine origin. Br. J. Cancer 2004, 90, 2418-2424. (Pubitemid 38961909)